Kolexia
Darbas Tiffany Oncologie médicale
Darbas Tiffany
Oncologie médicale
Hôpital Dupuytren
Limoges, France
37 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Sarcopénie Néphrocarcinome Tumeurs colorectales Surpoids COVID-19 Tumeurs de l'oesophage Obésité Tumeurs embryonnaires et germinales

Collaborateurs

Voir plus
Deluche Elise
Deluche Elise
Hôpital Dupuytren, Limoges, France
Peyramaure Clementine
Peyramaure Clementine
Hôpital Dupuytren, Limoges, France
Pestre-Munier Julia
Pestre-Munier Julia
Hôpital Dupuytren, Limoges, France
Le Brun-Ly Valerie
Le Brun-Ly Valerie
Hôpital Dupuytren, Limoges, France

Industries

Voir plus
Ipsen
6 collaboration(s)
Dernière en 2022
Amgen
4 collaboration(s)
Dernière en 2022
BMS
3 collaboration(s)
Dernière en 2023
Pfizer
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
ACACIAS 3: Learning about announcement consultations in the second cycle of medical studies.
Bulletin du cancer   01 décembre 2023
GIG-T: Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
Essai Clinique (Gustave-Roussy)   18 octobre 2023
2054P Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
SPICI: Strategic Treatment Pause of First-line Immune Check Point Inhibitor + VEGFR-Tyrosine Kinase Inhibitor in Good or Only One Adverse Prognostic Factor in Intermediate Risk Metastatic Renal Cell Carcinoma (mRCC) With an Objective Response: a Randomised, Non-inferiority Phase III Study
Essai Clinique (CHU Bordeaux)   10 mars 2023
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.
Frontiers in oncology   27 février 2023
FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX-bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.
International journal of cancer   14 juillet 2022
Extracellular Vesicle Measurements with Nanoparticle Tracking Analysis: A Different Appreciation of Up and Down Secretion.
International journal of molecular sciences   19 février 2022
Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
BMC cancer   07 décembre 2021
552P Reasons of screening failure during the 28-day screening period in patients identified for inclusion in phase I trials and their outcome
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Impact of Body Composition in Overweight and Obese Patients With Localised Renal Cell Carcinoma.
In vivo (Athens, Greece)   18 juin 2021